Torrent Investments declares no encumbrance on shares in FY26

1 min read     Updated on 06 Jun 2026, 01:52 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Torrent Investments Limited declared no encumbrance on Torrent Pharmaceuticals shares in FY26. The disclosure was filed under SEBI SAST Regulations on April 06, 2026.

powered bylight_fuzz_icon
42279715

*this image is generated using AI for illustrative purposes only.

Torrent Investments Limited has confirmed that it did not create any encumbrance on shares of Torrent Pharmaceuticals during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, covers both direct and indirect encumbrances made by the entity and persons acting in concert (PAC). This disclosure is significant for shareholders as it assures that the promoter group's holdings remain free from pledges or charges that could impact ownership stability.

The filing was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires acquirers to disclose any encumbrance on shares of the target company. Torrent Investments addressed the communication to the Corporate Relationship Department of BSE Limited and the Listing Department of National Stock Exchange of India Limited on April 06, 2026.

Entity Exchange Scrip Code
Torrent Pharmaceuticals Limited BSE 500420
Torrent Pharmaceuticals Limited NSE TORNTPHARM

The letter was signed by Deshna Shah, Company Secretary & Compliance Officer of Torrent Investments Limited. Copies of the declaration were also forwarded to the Company Secretary and the Chairman and Members of the Audit Committee of Torrent Pharmaceuticals Limited. Torrent Investments Limited, formerly known as Torrent Investments Private Limited, is registered at "Samanvay", 600, Tapovan, Ambawadi, Ahmedabad.

Historical Stock Returns for Torrent Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.87%-2.58%+3.98%+16.47%+40.92%+214.48%

How will the absence of share encumbrances impact Torrent Pharmaceuticals' ability to raise capital for future expansion?

What strategic shifts might Torrent Investments consider given the flexibility of having unpledged promoter holdings?

How does this clean holding position compare to industry peers in terms of financial stability and investor confidence?

Torrent Pharmaceuticals
View Company Insights
View All News
like17
dislike

Torrent Pharma AGM scheduled for June 23, 2026

1 min read     Updated on 04 Jun 2026, 12:44 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Torrent Pharmaceuticals Limited has scheduled its 53rd Annual General Meeting for June 23, 2026, via video conferencing. The meeting covers FY 2025-26, with e-voting open from June 19 to June 22. The company has issued the Notice and Integrated Annual Report, accessible via a specific web-link provided to shareholders.

powered bylight_fuzz_icon
41046871

*this image is generated using AI for illustrative purposes only.

Torrent Pharmaceuticals Limited has scheduled its 53rd Annual General Meeting (AGM) for June 23, 2026, at 9:30 a.m. via Video Conferencing and Other Audio Visual Means. The meeting will cover the financial year 2025-26, and the company has issued the Notice of AGM and Integrated Annual Report to shareholders. Members holding shares as of the cut-off date, June 16, 2026, are eligible to participate and vote at the meeting.

Pursuant to Regulation 36(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Notice and Integrated Annual Report were sent electronically to members with registered email addresses. For shareholders whose email addresses are not registered with the Registrar & Share Transfer Agent or Depository Participants, the company dispatched a letter containing a specific web-link to access the Integrated Annual Report for FY 2025-26.

E-Voting Schedule

The remote e-voting facility is available from 9:00 a.m. on June 19, 2026, until 5:00 p.m. on June 22, 2026. Shareholders who cast their votes during this remote e-voting period are not entitled to vote again during the AGM. However, members who do not participate in remote e-voting may exercise their franchise through the e-voting system during the meeting.

To facilitate the login process for e-voting, the company has outlined requirements for different shareholder categories. Physical shareholders must email their Folio No., name, and self-attested copies of PAN and Aadhaar cards. Demat holders are required to provide their 16-digit beneficiary ID (CDSL) or DP ID plus Client ID (NSDL), along with their name, client master list or statement copy, and self-attested PAN and Aadhaar cards.

Access and Support

The Integrated Annual Report is accessible via the provided web-link and through the Investors section of the company website. Shareholders facing technical difficulties with login via depositories can reach out to the respective helpdesks for assistance.

Login Type Helpdesk Details
CDSL Demat Holders Email: helpdesk.evoting@cdslindia.com or call Toll Free: 1800 21 09911
NSDL Demat Holders Email: evoting@nsdl.co.in or call: 022-48867050, 022-24997050

For general queries regarding the e-voting process, members may refer to the FAQs and e-voting manual available on the CDSL website.

Historical Stock Returns for Torrent Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.87%-2.58%+3.98%+16.47%+40.92%+214.48%

What key agenda items or resolutions are expected to be proposed during the 53rd AGM?

How might the financial results for FY 2025-26 influence Torrent Pharmaceuticals' strategic direction?

What are the anticipated shareholder concerns regarding the company's performance over the past year?

Torrent Pharmaceuticals
View Company Insights
View All News
like17
dislike

More News on Torrent Pharmaceuticals

1 Year Returns:+40.92%